127 related articles for article (PubMed ID: 32051091)
1. Resectable pancreas adenocarcinoma: the longer the wait time, the longer the oncologic survival?
Chen ZL; Yang T; Liang YJ
HPB (Oxford); 2020 May; 22(5):789. PubMed ID: 32051091
[No Abstract] [Full Text] [Related]
2. Response to letter "resectable pancreas adenocarcinoma: the longer the wait time, the longer the oncologic survival?".
Vasilyeva E; Li J; Desai S; Scudamore C; Segedi M; Chung S; Kim P
HPB (Oxford); 2020 Jun; 22(6):934. PubMed ID: 32291176
[No Abstract] [Full Text] [Related]
3. Impact of surgical wait times on oncologic outcomes in resectable pancreas adenocarcinoma.
Vasilyeva E; Li J; Desai S; Chung SW; Scudamore CH; Segedi M; Kim PT
HPB (Oxford); 2020 Jun; 22(6):892-899. PubMed ID: 31732464
[TBL] [Abstract][Full Text] [Related]
4. The effect of wait times on oncological outcomes from periampullary adenocarcinomas.
McLean SR; Karsanji D; Wilson J; Dixon E; Sutherland FR; Pasieka J; Ball C; Bathe OF
J Surg Oncol; 2013 Jun; 107(8):853-8. PubMed ID: 23625192
[TBL] [Abstract][Full Text] [Related]
5. [Analysis on the clinical therapeutic effects of arterial first approach pancreatoduodenectomy in the treatment of borderline resectable pancreatic adenocarcinoma].
Jin G; Zheng KL; Guo SW; Shao Z; Liu C; Shi XH; Liu RD; Bai SJ; Jiang H; Bian Y; Hu XG
Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):909-915. PubMed ID: 29224265
[No Abstract] [Full Text] [Related]
6. ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas.
Evans DB; Hess KR; Pisters PW
Ann Surg; 2002 Nov; 236(5):694; author reply 694-6. PubMed ID: 12409677
[No Abstract] [Full Text] [Related]
7. Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma?
Marchegiani G; Andrianello S; Perri G; Secchettin E; Maggino L; Malleo G; Bassi C; Salvia R
HPB (Oxford); 2018 May; 20(5):411-417. PubMed ID: 29191689
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.
Adams RB; Allen PJ
Ann Surg Oncol; 2009 Jul; 16(7):1745-50. PubMed ID: 19396494
[No Abstract] [Full Text] [Related]
9. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
Mehta VK; Fisher G; Ford JA; Poen JC; Vierra MA; Oberhelman H; Niederhuber J; Bastidas JA
J Gastrointest Surg; 2001; 5(1):27-35. PubMed ID: 11309645
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the pancreas: current management of resectable and locally advanced disease.
Evans DB; Rich TA; Byrd DR; Ames FC
South Med J; 1991 May; 84(5):566-70. PubMed ID: 2035074
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
[TBL] [Abstract][Full Text] [Related]
12. Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?
Healy GM; Redmond CE; Murphy S; Fleming H; Haughey A; Kavanagh R; Swan N; Conlon KC; Malone DE; Ryan ER
Abdom Radiol (NY); 2018 Mar; 43(3):620-628. PubMed ID: 28695235
[TBL] [Abstract][Full Text] [Related]
13. Management of adenocarcinoma of the body and tail of the pancreas.
Brennan MF; Moccia RD; Klimstra D
Ann Surg; 1996 May; 223(5):506-11; discussion 511-2. PubMed ID: 8651741
[TBL] [Abstract][Full Text] [Related]
14. [Oncologic risk in pylorus preservation in resection of ductal pancreas carcinoma].
Gerdes B; Ramaswamy A; Bartsch D; Rothmund M
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1087-9. PubMed ID: 9574341
[TBL] [Abstract][Full Text] [Related]
15. Waiting time to surgery and pancreatic cancer survival: A nationwide population-based cohort study.
Kirkegård J; Mortensen FV; Hansen CP; Mortensen MB; Sall M; Fristrup C
Eur J Surg Oncol; 2019 Oct; 45(10):1901-1905. PubMed ID: 31160135
[TBL] [Abstract][Full Text] [Related]
16. Preoperative versus postoperative adjuvant therapy for adenocarcinoma of the pancreas.
Hoffman JP; Stitzenberg KB
Adv Surg; 2009; 43():189-98. PubMed ID: 19845178
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the pancreas and periampullary region: a 41 year experience.
Coutsoftides T; Macdonald J; Shibata HR
Ann Surg; 1977 Dec; 186(6):730-3. PubMed ID: 603275
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT.
O'Malley ME; Boland GW; Wood BJ; Fernandez-del Castillo C; Warshaw AL; Mueller PR
AJR Am J Roentgenol; 1999 Dec; 173(6):1513-8. PubMed ID: 10584794
[TBL] [Abstract][Full Text] [Related]
19. Radiological tumor density and lymph node size correlate with survival in resectable adenocarcinoma of the pancreatic head: A retrospective cohort study.
Vyas SJ; Puri YS; John BJ; Yu D; Watkins J; Imber C; Fusai G; Arjun S; Sharma D; Davidson BR; Malago M; Rahman S
J Cancer Res Ther; 2016; 12(1):417-21. PubMed ID: 27072273
[TBL] [Abstract][Full Text] [Related]
20. Advances in borderline resectable pancreatic adenocarcinoma.
Vadehra D; Salibi PN; McHaffie DR; Sulzer J; Iannitti DA; Hwang JJ
Clin Adv Hematol Oncol; 2020 May; 18(5):280-288. PubMed ID: 32628656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
